D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor

Molecular Pharmacology

Volumn 68, Issue 3, 2005, Pages 568-578

  So, Christopher H ^b   Varghese, George ^b   Curley, Kevin J ^b   Kong, Michael M C ^b   Alijaniaram, Mohammed ^b   Ji, Xiaodong ^b   Nguyen, Tuan ^b   O'Dowd, Brian F ^b   George, Susan R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CALCIUM; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; OLIGOMER; PHOSPHOLIPASE C; QUINPIROLE;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL STRAIN HEK293; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; OLIGOMERIZATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; SURFACE PROPERTY;

ANIMALS; BIOPOLYMERS; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCYTOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MICROSCOPY, CONFOCAL; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 23944467820     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.012229     Document Type: Article

References (29)

1. Aizman O, Brismar H, Uhlen P, Zettergren E, Levey AI, Forssberg H, Greengard P, and Aperia A (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3:226-230.
2. Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, et al. (2003) Adenosine A2A-dopamine D2 receptorreceptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278:46741-46749.
3. 3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 8:291-303.
4. Fishburn CS, Elazar Z, and Fuchs S (1995) Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor. J Biol Chem 270:29819-29824.
5. Franco R, Ferre S, Agnati L, Torvinen M, Gines S, Hillion J, Casado V, Lledo P, Zoli M, Lluis C, et al. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23:S50-9, 2000.
6. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
7. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GY, and O'Dowd BF (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem 273:30244-30248.
8. George SR, O'Dowd BF, and Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820.
9. Ito K, Haga T, Lameh J, and SadeeW(1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119.
10. Kim SJ, Kim MY, Lee EJ, Ahn YS, and Baik JH (2004) Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor. Mol Endocrinol 18:640-652.
11. Kita K, Shiratani T, Takenouchi K, Fukuzako H, and Takigawa M (1999) Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats. Eur Neuropsychopharmacol 9:1-7.
12. Lamey M, Thompson M, Varghese G, Chi H, Sawzdargo M, George SR, and O'Dowd BF (2002) Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor. J Biol Chem 277:9415-9421.
13. Lee SP, O'Dowd BF, Ng GY, Varghese G, Akil H, Mansour A, Nguyen T, and George SR (2000) Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol Pharmacol 58:120-128.
14. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, and George SR (2004) Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279:35671-35678.
15. Lidow MS (2003) Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43:70-84.
16. Ma D, Zerangue N, Lin YF, Collins A, Yu M, Jan YN, and Jan LY (2001) Role of ER export signals in controlling surface potassium channel numbers. Science (Wash DC) 291:316-319.
17. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, and Milligan G (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human δ-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099.
18. Ng GY, Varghese G, Chung HT, Trogadis J, Seeman P, O'Dowd BF, and George SR (1997) Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology 138:4199-4206.
19. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, and Schwartz JC (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature (Lond) 353:164-167.
20. Pollack A (2004) Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers and theirs. Sci STKE 2004:pe50.
21. Prou D, Gu WJ, Le Crom S, Vincent JD, Salamero J, and Vernier P (2001) Intracellular retention of the two isoforms of the D(2) dopamine receptor promotes endoplasmic reticulum disruption. J Cell Sci 114:3517-3527.
22. 3H]spiperone. Mol Pharmacol 63:456-462.
23. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, and Bouvier M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17:677-691.
24. Toews ML (2000) Radioligand-binding assays for G protein-coupled receptor internalization, in Regulation of G Protein-Coupled Receptor Function and Expression (Benovic JL, ed) pp 199-230, Wiley-Liss, New York.
25. Vickery RG and von Zastrow M (1999) Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J Cell Biol 144:31-43.
26. Waszczak BL, Martin LP, Finlay HE, Zahr N, and Stellar JR (2002) Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. J Pharmacol Exp Ther 300:850-861.
27. Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, and Hall RA (2003) Heterodimerization of α2A- and β1-adrenergic receptors. J Biol Chem 278:10770-10777.
28. Zerangue N, Schwappach B, Jan YN, and Jan LY (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22:537-548.
29. Zhang LJ, Lachowicz JE, and Sibley DR (1994) The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 45:878-889.